Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment.
Claveau JS, Murray DL, Dispenzieri A, Kapoor P, Binder M, Buadi F, Dingli D, Fonder A, Gertz M, Gonsalves W, Hayman S, Hobbs M, Hwa YL, Kourelis T, Lacy M, Leung N, Lin Y, Warsame R, Kyle RA, Rajkumar V, Kumar SK. Claveau JS, et al. Among authors: rajkumar v. Leukemia. 2024 Aug;38(8):1863. doi: 10.1038/s41375-024-02307-6. Leukemia. 2024. PMID: 38886490 No abstract available.
Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival.
Van Ness B, Ramos C, Haznadar M, Hoering A, Haessler J, Crowley J, Jacobus S, Oken M, Rajkumar V, Greipp P, Barlogie B, Durie B, Katz M, Atluri G, Fang G, Gupta R, Steinbach M, Kumar V, Mushlin R, Johnson D, Morgan G. Van Ness B, et al. Among authors: rajkumar v. BMC Med. 2008 Sep 8;6:26. doi: 10.1186/1741-7015-6-26. BMC Med. 2008. PMID: 18778477 Free PMC article.
Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.
Ziv E, Dean E, Hu D, Martino A, Serie D, Curtin K, Campa D, Aftab B, Bracci P, Buda G, Zhao Y, Caswell-Jin J, Diasio R, Dumontet C, Dudziński M, Fejerman L, Greenberg A, Huntsman S, Jamroziak K, Jurczyszyn A, Kumar S, Atanackovic D, Glenn M, Cannon-Albright LA, Jones B, Lee A, Marques H, Martin T, Martinez-Lopez J, Rajkumar V, Sainz J, Juul Vangsted A, Watek M, Wolf J, Slager S, Camp NJ, Canzian F, Vachon C. Ziv E, et al. Among authors: rajkumar v. Nat Commun. 2015 Dec 9;6:10203. doi: 10.1038/ncomms10203. Nat Commun. 2015. PMID: 26648255 Free PMC article. No abstract available.
A role for IFN-lambda1 in multiple myeloma B cell growth.
Novak AJ, Grote DM, Ziesmer SC, Rajkumar V, Doyle SE, Ansell SM. Novak AJ, et al. Among authors: rajkumar v. Leukemia. 2008 Dec;22(12):2240-6. doi: 10.1038/leu.2008.263. Epub 2008 Oct 2. Leukemia. 2008. PMID: 18830264 Free PMC article.
A novel report of cig-FISH and cytogenetics in POEMS syndrome.
Bryce AH, Ketterling RP, Gertz MA, Lacy M, Knudson RA, Kumar S, Kyle RA, Fonseca R, Greipp PR, Lust JA, Rajkumar VS, Hayman SR, Buadi F, Russell SJ, Zeldenrust SR, Dispenzieri A. Bryce AH, et al. Am J Hematol. 2008 Nov;83(11):840-1. doi: 10.1002/ajh.21285. Am J Hematol. 2008. PMID: 18839437 Free PMC article.
Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kourelis TV, Gertz M, Zent C, Lacy M, Kyle R, Kapoor P, Zeldenrust S, Buadi F, Witzig T, Hayman S, Lust J, Russell S, Lin Y, Rajkumar VS, Kumar S, Leung N, Dingli D, Dispenzieri A. Kourelis TV, et al. Among authors: rajkumar vs. Am J Hematol. 2013 May;88(5):375-8. doi: 10.1002/ajh.23413. Epub 2013 Mar 19. Am J Hematol. 2013. PMID: 23508840 Free article.
Quantification of clonal circulating plasma cells in relapsed multiple myeloma.
Gonsalves WI, Morice WG, Rajkumar V, Gupta V, Timm MM, Dispenzieri A, Buadi FK, Lacy MQ, Singh PP, Kapoor P, Gertz MA, Kumar SK. Gonsalves WI, et al. Among authors: rajkumar v. Br J Haematol. 2014 Nov;167(4):500-5. doi: 10.1111/bjh.13067. Epub 2014 Aug 12. Br J Haematol. 2014. PMID: 25113422 Free PMC article. Clinical Trial.
Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study.
Kumar SK, Berdeja JG, Niesvizky R, Lonial S, Laubach JP, Hamadani M, Stewart AK, Hari P, Roy V, Vescio R, Kaufman JL, Berg D, Liao E, Di Bacco A, Estevam J, Gupta N, Hui AM, Rajkumar V, Richardson PG. Kumar SK, et al. Among authors: rajkumar v. Lancet Oncol. 2014 Dec;15(13):1503-1512. doi: 10.1016/S1470-2045(14)71125-8. Epub 2014 Nov 14. Lancet Oncol. 2014. PMID: 25456369 Clinical Trial.
168 results